Town Health International Medical Group Limited provided consolidated earnings guidance for the Year Ended 31 December 2023. For the period, the company expected 2023, the Group will record a consolidated loss attributable to Shareholders in the range of approximately HKD 165 million to HKD 223 million and a consolidated loss in the range of approximately HKD 135 million to HKD 183 million respectively, as compared with the consolidated profit attributable to Shareholders of approximately HKD 15.3 million and the consolidated profit of approximately HKD 49.5 million recorded for the year ended 31 December 2022 respectively. Such significant change from consolidated profit attributable to Shareholders to consolidated loss attributable to Shareholders was mainly attributable to the net effects of (i) the increase in the revenue of the Group recorded for the year ended 31 December 2023 as compared with the revenue of the Group of approximately HKD 1,535.6 million recorded for the year ended 31 December 2022, as a result of (a) the increase in demand for medical services and managed medical network services as well as mainland hospital management services due to the rebound after the COVID-19 pandemic; and (b) the contribution from Central Medical Holdings Limited after the Group's acquisition in August 2022; (ii) the significant increase on fair value loss of the Group's investment properties recorded for the year ended 31 December 2023 from the fair value loss of approximately HKD 6.9 million recorded for the year ended 31 December 2022; and (iii) the significant increase on impairment losses recognized on the Group's various assets recorded for the year ended 31 December 2023 from the impairment losses of approximately HKD 4.9 million recorded for the year ended 31 December 2022.